Risk Factors for Prognosis of Lung Cancer Patients Receiving Anlotinib Treatment: A Retrospective Cohort Study - Xie, Congyi; Chen, Jinzhan; Yang, Shuwen; Ye, Feiyang; Lin, Zhenyang; Xu, Yijiao; Yang, Yimin; Tong, Lin (The clinical respiratory journal, 2025)
Keywords: Adult; Aged; anlotinib; Biomarkers, Tumor - blood; Cohort analysis; Female; Health risks; Humans; Indoles - administration & dosage; Indoles - therapeutic use; Kaplan-Meier Estimate; Lung cancer; Lung Neoplasms - blood; Lung Neoplasms - drug therapy; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Male; Medical prognosis; Middle Aged; Natriuretic Peptide, Brain; Neoplasm Staging; Original; Peptide Fragments - blood; Phosphopyruvate Hydratase - blood; Prognosis; Quinolines - administration & dosage; Quinolines - therapeutic use; Retrospective Studies; Risk Factors; survival; lung cancer; anlotinib; survival